PCN18 Matching-Adjusted Indirect Comparison (MAIC) of Entrectinib Versus Crizotinib in Patients with ROS1 NON-SMALL CELL LUNG Cancer (NSCLC): An Updated Analysis
| Autor: | Chu, P., Mitchell, C.R., Batson, S., Aziez, A., Antoniou, M. |
|---|---|
| Zdroj: | In Value in Health December 2020 23 Supplement 2:S423-S424 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect